Dover has entered right into a definitive agreement to amass Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will expand Dover’s biopharma single-use production offering, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue in the course of the full yr 2022.
When the deal closes, Malema will turn out to be part of the PSG enterprise unit within Dover’s Pumps & Process Solutions phase.
“We see an incredible long-term growth alternative within the bioprocessing industry driven by a robust and rising pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of extra efficient single-use production processes supports a robust outlook for our choices of single-use components to end-customers. We imagine that pairing Malema’s know-how with our present portfolio of single-use pumps for biopharma processing will greatly enhance the accuracy and worth proposition of our solutions to our customers.”
เกจแรงดันลม are methodically building out our biopharma platform by way of proactive capacity additions, new product improvement, and opportunistic acquisitions of highly-attractive area of interest element technologies,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and additional strengthens our sensor portfolio with new proprietary technology. In addition to enticing biopharma applications, we count on strong progress within the semiconductor area on the capacity growth and re-shoring tailwinds.”
Share